Supernus Pharmaceuticals (SUPN) Goodwill & Intangibles: 2011-2025
Historic Goodwill & Intangibles for Supernus Pharmaceuticals (SUPN) over the last 14 years, with Sep 2025 value amounting to $742.6 million.
- Supernus Pharmaceuticals' Goodwill & Intangibles rose 12.99% to $742.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $742.6 million, marking a year-over-year increase of 12.99%. This contributed to the annual value of $638.9 million for FY2024, which is 10.88% down from last year.
- As of Q3 2025, Supernus Pharmaceuticals' Goodwill & Intangibles stood at $742.6 million, which was up 24.11% from $598.3 million recorded in Q2 2025.
- Supernus Pharmaceuticals' Goodwill & Intangibles' 5-year high stood at $902.2 million during Q4 2021, with a 5-year trough of $424.6 million in Q3 2021.
- For the 3-year period, Supernus Pharmaceuticals' Goodwill & Intangibles averaged around $698.5 million, with its median value being $696.8 million (2024).
- The largest annual percentage gain for Supernus Pharmaceuticals' Goodwill & Intangibles in the last 5 years was 1,751.85% (2021), contrasted with its biggest fall of 13.60% (2021).
- Quarterly analysis of 5 years shows Supernus Pharmaceuticals' Goodwill & Intangibles stood at $902.2 million in 2021, then fell by 9.17% to $819.5 million in 2022, then decreased by 12.52% to $716.9 million in 2023, then declined by 10.88% to $638.9 million in 2024, then grew by 12.99% to $742.6 million in 2025.
- Its Goodwill & Intangibles was $742.6 million in Q3 2025, compared to $598.3 million in Q2 2025 and $619.1 million in Q1 2025.